LNAI ▲ +4.3% - Lunai Bioworks Inc. $LNAI Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement Lunai Bioworks (NASDAQ: LNAI) rose 4.3% today following the announcement of an exclusive agreement with Tanaist to expand its Parkinson's disease platform. The expansion of the company's pipeline in a major neurological indication appears to have lifted investor sentiment for the stock. 22-SEP-2026 09:21 AM ET